Indefinite Delivery Contract SPE2DU25D9802

The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government agencies.

The $499,999,999 single-award IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers a diverse portfolio of pharmaceutical products across various categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain. This IDC was awarded under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to DoD customers, the U.S. Coast Guard, and other government agencies.